Penn Avenue Law & Policy is proudly focused on select areas of FDA law. Christine P. Bump’s experience is concentrated in devices, digital health, diagnostics, wellness, genetics and genomics, and advertising and promotion. Penn Avenue Law & Policy is an insightful, attentive, and efficient practice that develops FDA strategies for cutting-edge technologies. Christine advises CEOs, scientists, and teams of all levels regarding clinical investigations, premarket submissions, pre- and postmarket compliance, and promotional issues. She counsels a variety of clients, including start-ups, national and multi-national corporations, venture capital groups, and portfolio companies on navigating the FDA process.